Sampath Gunda1, Madhu Reddy1, Jayasree Pillarisetti1, Moustapha Atoui1, Nitish Badhwar1, Vijay Swarup1, Luigi DiBiase1, Sanghamitra Mohanty1, Prashanth Mohanty1, Hosakote Nagaraj1, Christopher Ellis1, Abdi Rasekh1, Jie Cheng1, Krzysztof Bartus1, Randall Lee1, Andrea Natale1, Dhanunjaya Lakkireddy2. 1. From the Department of Cardiology, Mid-America Cardiology and University of Kansas Medical Center, Kansas City (S.G., M.R., J.P., M.A., D.L.); Department of Cardiology, University of California, San Francisco (N.B., R.L.); Department of Cardiology, Arizona Heart Rhythm Center, Phoenix (V.S.); Department of Cardiology, Montefiore Medical Center, Bronx, NY (L.D.); Department of Cardiology, Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin (S.M., P.M., A.N.); Nebraska Heart Institute, Lincoln (H.N.); Department of Cardiology, Vanderbilt University Medical Center, Nashville, TN (C.E.); Department of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston (A.R.); Department of Cardiology, Texas Heart Institute, Houston (J.C.); and Department of Cardiology, Jagiellonian University, Krakow, Poland (K.B.). 2. From the Department of Cardiology, Mid-America Cardiology and University of Kansas Medical Center, Kansas City (S.G., M.R., J.P., M.A., D.L.); Department of Cardiology, University of California, San Francisco (N.B., R.L.); Department of Cardiology, Arizona Heart Rhythm Center, Phoenix (V.S.); Department of Cardiology, Montefiore Medical Center, Bronx, NY (L.D.); Department of Cardiology, Texas Cardiac Arrhythmia Institute, St. David's Medical Center, Austin (S.M., P.M., A.N.); Nebraska Heart Institute, Lincoln (H.N.); Department of Cardiology, Vanderbilt University Medical Center, Nashville, TN (C.E.); Department of Cardiology, Texas Heart Institute at St. Luke's Episcopal Hospital, Houston (A.R.); Department of Cardiology, Texas Heart Institute, Houston (J.C.); and Department of Cardiology, Jagiellonian University, Krakow, Poland (K.B.). dlakkireddy@gmail.com.
Abstract
BACKGROUND: A dry epicardial access (EA) is increasingly used for advanced cardiovascular procedures. Conventionally used large bore needles (Tuohy or Pajunk needle; LBN) have been associated with low but definite incidence of major complications with EA. Use of micropuncture needle (MPN) may decrease the risk of complications. We intended to compare the outcomes of LBN with MPN for EA. METHODS AND RESULTS: We report a multicenter observational study of consecutive patients who underwent EA for ventricular tachycardia ablation or Lariat procedure using the LBN or MPN. Oral anticoagulation was stopped before the procedure. Baseline characteristics and procedure-related complications were collected and compared. Of the 404 patients, LBN and MPN were used in 46% and 54% of patients, respectively. There was no significant difference in the incidence of inadvertent puncture of myocardium between LBN and MPN (7.6% versus 6.8%, P=0.76). However, there was a significantly higher rate of large pericardial effusions with LBN compared with MPN (8.1% versus 0.9%; P<0.001). The incidence of pleural effusions were not significantly different between both (1.6% versus 2.3%; P=0.64). LBN group had an increase in other complications compared with MPN (open heart surgery to repair cardiac laceration [6 versus 0], injury to liver [1 versus 0], coronaries [1 versus 0], and superior epigastric artery requiring surgical exploration [0 versus 1]). CONCLUSIONS: The use of MPN is associated with decreased incidence of major complications, and the need for surgical repair and routine use should be considered for EA.
BACKGROUND: A dry epicardial access (EA) is increasingly used for advanced cardiovascular procedures. Conventionally used large bore needles (Tuohy or Pajunk needle; LBN) have been associated with low but definite incidence of major complications with EA. Use of micropuncture needle (MPN) may decrease the risk of complications. We intended to compare the outcomes of LBN with MPN for EA. METHODS AND RESULTS: We report a multicenter observational study of consecutive patients who underwent EA for ventricular tachycardia ablation or Lariat procedure using the LBN or MPN. Oral anticoagulation was stopped before the procedure. Baseline characteristics and procedure-related complications were collected and compared. Of the 404 patients, LBN and MPN were used in 46% and 54% of patients, respectively. There was no significant difference in the incidence of inadvertent puncture of myocardium between LBN and MPN (7.6% versus 6.8%, P=0.76). However, there was a significantly higher rate of large pericardial effusions with LBN compared with MPN (8.1% versus 0.9%; P<0.001). The incidence of pleural effusions were not significantly different between both (1.6% versus 2.3%; P=0.64). LBN group had an increase in other complications compared with MPN (open heart surgery to repair cardiac laceration [6 versus 0], injury to liver [1 versus 0], coronaries [1 versus 0], and superior epigastric artery requiring surgical exploration [0 versus 1]). CONCLUSIONS: The use of MPN is associated with decreased incidence of major complications, and the need for surgical repair and routine use should be considered for EA.
Authors: Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Saenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld Journal: J Interv Card Electrophysiol Date: 2020-10 Impact factor: 1.900
Authors: Thomas Fink; Michael Schlüter; Roland Richard Tilz; Christian-Hendrik Heeger; Christine Lemes; Tilmann Maurer; Bruno Reissmann; Laura Rottner; Francesco Santoro; Shibu Mathew; Andreas Rillig; Feifan Ouyang; Karl-Heinz Kuck; Andreas Metzner Journal: Clin Res Cardiol Date: 2018-06-07 Impact factor: 5.460
Authors: David Duncker; Philipp Sommer; Sonia Busch; Roland R Tilz; Till Althoff; Leon Iden; Andreas Metzner; Andreas Rillig; K R Julian Chun; Felix Bourier; Tilman Maurer; Dong-In Shin Journal: Herzschrittmacherther Elektrophysiol Date: 2021-05-19
Authors: Edmond M Cronin; Frank M Bogun; Philippe Maury; Petr Peichl; Minglong Chen; Narayanan Namboodiri; Luis Aguinaga; Luiz Roberto Leite; Sana M Al-Khatib; Elad Anter; Antonio Berruezo; David J Callans; Mina K Chung; Phillip Cuculich; Andre d'Avila; Barbara J Deal; Paolo Della Bella; Thomas Deneke; Timm-Michael Dickfeld; Claudio Hadid; Haris M Haqqani; G Neal Kay; Rakesh Latchamsetty; Francis Marchlinski; John M Miller; Akihiko Nogami; Akash R Patel; Rajeev Kumar Pathak; Luis C Sáenz Morales; Pasquale Santangeli; John L Sapp; Andrea Sarkozy; Kyoko Soejima; William G Stevenson; Usha B Tedrow; Wendy S Tzou; Niraj Varma; Katja Zeppenfeld Journal: Europace Date: 2019-08-01 Impact factor: 5.214
Authors: Ammar M Killu; Alan M Sugrue; Siva K Mulpuru; Christopher J McLeod; David O Hodge; Peter A Noseworthy; Lisa Fanning; Thomas M Munger; Douglas L Packer; Samuel J Asirvatham; Paul A Friedman Journal: J Interv Card Electrophysiol Date: 2016-05-18 Impact factor: 1.900